Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01454297
What this trial is testing

Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

Who this might be right for
Multiple Myeloma
Multiple Myeloma Research Foundation 1,154
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07287852
What this trial is testing

A Pilot Study to Examine the Effect of Egb761 on Plasma Biomarker Levels and on Cognitive Function in Patients With MCI

Who this might be right for
Alzheimer Disease (AD)Mild Cognitive Impairment (MCI)
Hadassah Medical Organization 50
Testing effectiveness (Phase 2)Study completedNCT00670631
What this trial is testing

Tandem Transplantation in Multiple Myeloma (MM) Patients With <12 Months of Prior Treatment

Who this might be right for
Multiple Myeloma
Guido Tricot 46
Not applicableStudy completedNCT04187183
What this trial is testing

Use of Fresh Platelet Rich Plasma With Concentrated Leukocytes or Fresh Platelet Rich Plasma Without Concentrated Leukocytes in the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial

Who this might be right for
Osteoarthritis, Knee
Istituto Ortopedico Rizzoli 132
Large-scale testing (Phase 3)Not Yet RecruitingNCT07728188
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
AbbVie 520
Not applicableNot Yet RecruitingNCT07711327
What this trial is testing

Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy

Who this might be right for
Atrial Fibrillation (AF)Chronic Lymphocytic LeukemiaWaldenstrom Macroglobulinemia+2 more
Tina Baykaner 500
Early research (Phase 1)Ended earlyNCT02036502
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)

Who this might be right for
Multiple Myeloma
Merck Sharp & Dohme LLC 77
Large-scale testing (Phase 3)Looking for participantsNCT06561854
What this trial is testing

Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone

Who this might be right for
Multiple MyelomaRelapse Multiple Myeloma
Assistance Publique - Hôpitaux de Paris 318
Testing effectiveness (Phase 2)Study completedNCT00793572
What this trial is testing

Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 32
Large-scale testing (Phase 3)UnknownNCT03720041
What this trial is testing

Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Leeds 740
Large-scale testing (Phase 3)Ended earlyNCT04361253
What this trial is testing

Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy

Who this might be right for
COVIDInfectious Disease
Brigham and Women's Hospital 45
Testing effectiveness (Phase 2)WithdrawnNCT02986451
What this trial is testing

Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory Myeloma

Who this might be right for
Relapse/Refractory Multiple Myeloma
Sun Yat-sen University
Large-scale testing (Phase 3)Study completedNCT00205751
What this trial is testing

Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy

Who this might be right for
Multiple Myeloma
Austrian Forum Against Cancer 350
Post-approval studies (Phase 4)Study completedNCT01554670
What this trial is testing

Radio-frequency (RF)-Based Plasma Micro-tenotomy for the Treatment of Shoulder Impingement Syndrome

Who this might be right for
Rotator Cuff Shoulder Syndrome and Allied Disorders
Beijing Hospital 65
Post-approval studies (Phase 4)Looking for participantsNCT05722405
What this trial is testing

Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Not applicableEnded earlyNCT03870451
What this trial is testing

Cryocompression Therapy for Peripheral Neuropathy in Patients With Multiple Myeloma

Who this might be right for
Chemotherapy-induced Peripheral NeuropathyPlasma Cell Myeloma
Wake Forest University Health Sciences 18
Not applicableUnknownNCT03776877
What this trial is testing

Endovascular Treatment in Ischemic Stroke Follow-up Evaluation

Who this might be right for
Stroke, Acute
Hopital Foch 4,000
Early research (Phase 1)Active Not RecruitingNCT06369467
What this trial is testing

Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy

Who this might be right for
Food Allergy
Regeneron Pharmaceuticals 6
Testing effectiveness (Phase 2)Study completedNCT00083902
What this trial is testing

Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy

Who this might be right for
Multiple Myeloma
University of Arkansas 190
Testing effectiveness (Phase 2)WithdrawnNCT04361851
What this trial is testing

Study of Dara-Pembro for Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Wake Forest University Health Sciences
Next Page